1型糖尿病终末期肾病验证预测模型
基于丹麦5460例1型糖尿病成人队列(2001-2016年)开发竞争风险ESKD预测模型,纳入年龄、性别、糖尿病病程、eGFR、白蛋白尿等常规指标,5年风险区分度C统计量0.888,并在丹麦和苏格兰9175例成人中外部验证确认。
要点
- 模型纳入年龄、性别、病程、eGFR、白蛋白尿、血压、HbA1c、吸烟和心血管病史。
- 5年ESKD风险C统计量在推导队列为0.888,外部验证队列为0.865和0.961。
- 该模型可用于成人1型糖尿病ESKD风险分层,辅助早期干预决策。
核心结论
- 开发并验证了一个高性能的成人1型糖尿病ESKD预测模型,可用于风险分层。
研究设计与样本
- 基于丹麦人群的5460例临床诊断1型糖尿病成人队列,2001至2016年随访,采用泊松回归开发竞争风险模型,并在丹麦和苏格兰9175例成人中外部验证。
主要发现
- 中位随访10.4年(四分位限5.1;14.7),303例(5.5%)发生ESKD,764例(14.0%)未发生ESKD即死亡。
- 最终模型纳入年龄、男性、糖尿病病程、eGFR、微量及大量白蛋白尿、收缩压、HbA1c、吸烟和既往心血管疾病。
- 5年ESKD风险C统计量在推导队列为0.888(95%CI 0.849;0.927),丹麦外部验证队列为0.865(0.811;0.919),苏格兰外部验证队列为0.961(0.940;0.981)。
临床怎么用
- 可基于常规临床检查指标计算5年ESKD风险,用于成人1型糖尿病患者的风险分层和早期干预决策。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: End-stage kidney disease (ESKD) is a life-threatening complication of diabetes that can be prevented or delayed by intervention. Hence, early detection of people at increased risk is essential. RESEARCH DESIGN AND METHODS: From a population-based cohort of 5,460 clinically diagnosed Danish adults with type 1 diabetes followed from 2001 to 2016, we developed a prediction model for ESKD accounting for the competing risk of death. Poisson regression analysis was used to estimate the model on the basis of information routinely collected from clinical examinations. The effect of including an extended set of predictors (lipids, alcohol intake, etc.) was further evaluated, and potential interactions identified in a survival tree analysis were tested. The final model was externally validated in 9,175 adults from Denmark and Scotland. RESULTS: During a median follow-up of 10.4 years (interquartile limits 5.1; 14.7), 303 (5.5%) of the participants (mean [SD] age 42.3 [16.5] years) developed ESKD, and 764 (14.0%) died without having developed ESKD. The final ESKD prediction model included age, male sex, diabetes duration, estimated glomerular filtration rate, micro- and macroalbuminuria, systolic blood pressure, hemoglobin A1c, smoking, and previous cardiovascular disease. Discrimination was excellent for 5-year risk of an ESKD event, with a C-statistic of 0.888 (95% CI 0.849; 0.927) in the derivation cohort and confirmed at 0.865 (0.811; 0.919) and 0.961 (0.940; 0.981) in the external validation cohorts from Denmark and Scotland, respectively. CONCLUSIONS: We have derived and validated a novel, high-performing ESKD prediction model for risk stratification in the adult type 1 diabetes population. This model may improve clinical decision making and potentially guide early intervention.
引用
- Vistisen D, Andersen GS, Hulman A, et al. A Validated Prediction Model for End-Stage Kidney Disease in Type 1 Diabetes. Diabetes Care. 2021. PMID: 33509931. doi:10.2337/dc20-2586
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。